Differential expression of DNA topoisomerase I gene between CPT-11 acquired-and native-resistant human pancreatic tumor cell lines: Detected by RNAPCR-based quantitation assay
- 1 April 1992
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 184 (2), 618-625
- https://doi.org/10.1016/0006-291x(92)90634-w
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sitesNucleic Acids Research, 1991
- Establishment and Characterization of Human Pancreatic Cancer Cell Lines in Tissue Culture and in Nude MiceJapanese Journal of Cancer Research, 1990
- Pancreastatin producing cell line from human pancreatic islet cell tumorBiochemical and Biophysical Research Communications, 1990
- Transcription of the dystrophin gene in human muscle and non-muscle tissuesNature, 1988
- Regulation of Xenopus laevis DNA topoisomerase I activity by phosphorylation in vitroBiochemistry, 1988
- Asynchronous regulation of mouse H-2D and beta-2 microglobulin RNA transcriptsImmunogenetics, 1985
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979
- Effects of camptothecin on RNA synthesis in leukemia L1210 cellsBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1971
- Camptothecin inhibits macromolecular synthesis in mammalian cells but not in isolated mitochondria or lE. coliBiochemical and Biophysical Research Communications, 1970
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966